How Piperacillin/Tazobactam works in pregnant women and newborns
Part of Genetic & congenital, Infections clinical trials.
This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are pregnant and your baby is at high risk of getting an infection shortly after birth.
- You are taking (or plan to take) the antibiotic Piperacillin/Tazobactam to prevent or treat infection.
- You must not have had a serious allergic reaction to this antibiotic before.
- You cannot be taking any other experimental medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for premature babies born at 26 to 34 weeks who have risk factors for early infection: giving antibiotics only if they develop signs of infection versus giving them right away. It aims to find out if waiting is safe and reduces unnecessary antibiotic use.
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.
This study looks at two antibiotics given during pregnancy: ceftriaxone (given as a shot or IV) for infections other than syphilis, and benzathine penicillin G (given as a shot) for syphilis. The goal is to learn more about how these medicines affect pregnant women and their babies.
This trial tests whether giving azithromycin during labor can prevent infections in mothers and newborns. It is for pregnant women who are otherwise healthy and have no risk factors for infection.
Hear when a new Early-Onset Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.